Results 21 to 30 of about 142,658 (312)
Frontiers in Pharmacology, 2022 Background: Limited data are available regarding the entire spectrum of interstitial lung disease with a progressive fibrosing feature. We investigated the prevalence and prognostic predictive characteristics in patients with PF-ILD.Methods: This ...
Yuanying Wang +8 more
doaj +1 more source
Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 2. Idiopathic Pulmonary Fibrosis [PDF]
, 2019 Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia, which presents with a progressive worsening dyspnea, and thus a poor outcome.
박무석, 이상훈
core +1 more source
Progressive fibrosis in interstitial lung diseases — proposed definition and management
, 2021 Interstitial lung diseases may have an unpredictably progressive course, which is manifested as progression of pulmonary fibrosis, causing an increasing impairment of lung function affecting a poor prognosis.
Piotrowski, Wojciech Jerzy; Department of Pneumology and Allergy, Medical University of Lodz, Lodz, Poland +1 more
core +1 more source
Diagnostic and prognostic biomarkers for chronic fibrosing interstitial lung diseases with a progressive phenotype [PDF]
, 2020 Biomarkers have the potential to become central to the clinical evaluation and monitoring of patients with chronic fibrosing interstitial lung diseases with a progressive phenotype.
Inoue, Y. +14 more
core +1 more source
Frontiers in Medicine, 2018 The enzyme telomerase reverse transcriptase (TERT) is essential for telomere maintenance. In replicating cells, maintenance of telomere length is important for the preservation of vital genetic information and prevention of genomic instability.
Reinier Snetselaar +5 more
doaj +1 more source
Interstitial Lung Diseases [PDF]
, 2019 Interstitial lung diseases are rare and diffuse, and their diagnosis is a challenge because it requires a multidisciplinary approach. Future trends in the treatment of these diseases requires knowledge of the molecular changes in various types of lung ...
core +1 more source
ANXA11 rs1049550 Associates with Löfgren’s Syndrome and Chronic Sarcoidosis
Cells, 2022 Sarcoidosis is an immune mediated granulomatous disease commonly affecting the lungs. Genome wide association studies identified many genomic regions that are shared among multiple immune mediated diseases.
Bekir Karakaya +5 more
doaj +1 more source
Genetic Interstitial Lung Disease [PDF]
Clinics in Chest Medicine, 2012 The interstitial lung diseases (ILDs), or diffuse parenchymal lung diseases, are a heterogeneous collection of more than 100 different pulmonary disorders that affect the tissue and spaces surrounding the alveoli. Patients affected by ILD usually present with shortness of breath or cough; for many, there is evidence of pulmonary restriction, decreased ...
Megan Stuebner, Devine +1 more
openaire +2 more sources
Clinical characteristics and lung function in older children vertically infected with Human Immunodeficiency Virus in Malawi [PDF]
, 2015 T. M. was funded by the Commonwealth scholarship, with research costs from a grant fom Helse Nord Northern Norway Regional Health Authority. E. L. C., R. A. F., and J. R. are supported by Wellcome Trust Fellowships (Senior Fellowship in Clinical Sciences
Webb, Emily L +22 more
core +1 more source
Progression of fibrosing interstitial lung disease [PDF]
, 2020 Fibrotic interstitial lung diseases (ILDs) are often challenging to diagnose and classify, but an accurate diagnosis has significant implications for both treatment and prognosis.
Guler, Sabina A. +3 more
core +1 more source